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LCX stenosis
p Value
1 2 3 4 5
LAD FFR baseline 0.940.03 0.920.02 0.920.02 0.920.02 0.920.02 0.936
LAD FFR hyperemia 0.930.04 0.850.03 0.890.03 0.880.03 0.900.03 0.310
LCX FFR baseline 1.000.01 0.990.01 0.970.01 0.930.01 0.330.01 <0.001
LCX FFR hyperemia 0.980.02 0.970.01 0.940.01 0.840.01 0.350.01 <0.001
Pa 62.05.2 61.75.2 61.75.2 63.05.2 56.75.2 <0.001
Pw 20.32.6 20.42.6 20.52.6 20.92.6 20.52.6 0.789
HR 77.13.7 77.63.5 77.63.5 78.83.5 78.93.5 0.883
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BACKGROUND FFR measurement is beneﬁcial to evaluate the func-
tional signiﬁcance of coronary artery stenosis and guiding coronary
interventions. The ACIST Navvus Microcatheter is a rapid exchange
intravascular catheter that can be passed into the coronary tree over
any 0.014” guidewire. The Navvus catheter has an in-lesion mean
distal shaft diameter of 0.022” with a maximum proﬁle of 0.036” at
the pressure sensor near the distal tip.
METHODS We compared FFR values measured with a new catheter
based pressure sensor to those measured with a traditional 0.014”
wire-based system (Volcano) across a wide range of stenosis severities
in 17 patients with ischemic heart disease. After diagnostic angiog-
raphy, FFR was obtained by both commercially available 0.014”
pressure wire (Volcano Verrata) and catheter based pressure sensor
(ACIST Navvus). Values were obtained in a sequential fashion over
several minutes under separate vasodilator administration, with
sensors placed independently in similar locations.
RESULTS Among 29 measurements (pre-PCI:20, post-PCI:9), success-
ful FFR measurement was obtained in 28/29 cases with the micro-
catheter system, and 28/29 cases with the wire based system. Both
cases where FFR was unsuccessful involved tortuous lesions. The
correlation of FFR values between both system was quite good and
acceptable across the wide range of stenosis severities (see ﬁgure),
with a predicted bias at the 0.80 cut point of 0.004, wire-based system
higher, (95% CI -0.02 to 0.02), by Passing-Bablok analysis.CONCLUSIONS Navvus can navigate difﬁcult anatomy with minimum
drift phenomenon. FFR correlation was quite good even in very se-
vere stenosis.
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BACKGROUND Fractional ﬂow reserve (FFR) has become standard
invasive assessment for determining the functional signiﬁcance of
coronary artery stenosis. Intravenous (IV) infusion of adenosine is the
gold standard method for the induction of hyperemia. Intracoronary
(IC) bolus injection of nicorandil, a coronary vasodilator which acts on
both macro- and microvascular systems, has been reported to be safe
and cardioprotective in patients with coronary artery disease.
METHODS We performed a patient-level pooled analysis of 5 previous
studies, which compared FFR measurement using IV adenosine/
adenosine triphosphate (ATP) and IC nicorandil. A total of 480 inter-
mediate coronary lesions from 429 patients were analyzed to evaluate
the safety and efﬁcacy of IC nicorandil as an alternative choice of
hyperemic agent for invasive physiologic studies.
RESULTS IC nicorandil showed signiﬁcantly earlier achievement of
maximum hyperemia (time-to-the lowest FFR: 18.0s [IQR 15.6-21.5]
vs. 44.0s [IQR 36.0-60.0], p<0.001) with similar hyperemic efﬁcacy,
compared with intravenous (IV) adenosine/ATP (FFR 0.82[0.75-0.87]
vs. 0.82[0.74-0.88], p¼0.207). FFR measurements with both agents
showed excellent correlation and classiﬁcation agreement (CA) for
FFR0.80 (r¼0.941, ICC 0.980, CA 90.8%, Kappa¼0.814, AUC of
nicorandil 0.980, all p<0.001). Only 3 patients (0.7%) showed
changes in classiﬁcation across the gray zone (0.75-0.80). IC nicor-
andil produced fewer changes in blood pressure (BP) and heart rate
(HR) and showed less chest pain than IV adenosine/ATP (all
p<0.001). When comparing DFFR according to DBP or DHR between
IV adenosine/ATP and IC nicorandil, there were no correlations,
either between DFFR and DBP (r¼-0.114, p¼0.091), or between DFFR
and DHR (r¼1.000, p¼0.151).Adenosine/ATP IV Nicorandil IC P valuen¼480
FFR 0.82 (0.74-0.88) 0.82 (0.75-0.87) 0.207n¼310
Time to the lowest
FFR, s44.0 (36.0-60.0) 18.0 (15.6-21.5) <0.001n¼74
Hyperemic mean
transit time, s0.20 (0.16-0.29) 0.20 (0.15-0.28) 0.098IMR, U 15.3 (12.7-20.0) 14.3 (11.2-20.3) 0.097n¼220
DBlood
pressure, mmHg-13.0 (-20.0 to -7.0) -10.0 (-14.0 to -4.25) <0.001DHeart rate, /min 6.0 (2.0-11.0) 3.0 (0.0-7.0) <0.001n¼212
VAS pain score 2.0 (0.0-4.0) 0.0 (0.0-0.0) <0.001n¼429
AV conduction
disturbance11 (2.3%) 0 (0%) <0.001Values are median and interquartile range (IQR) or mean  SD.
Abbreviations: IMR, index of microcirculatory resistance; VAS, visual analogue scale; AV, atrioventricular
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effective way to induce maximal hyperemia and can be used as a
substitute for adenosine.
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BACKGROUND The aim of this study was to provide and validate a
mathematical model of tandem lesion for the prediction of post-
stenting fractional ﬂow reserve (FFR) across the remaining stenosis
without a repeated FFR measurement.
METHODS Following treatment of either proximal or distal stenosis,
the residual FFR gradient across the remaining lesion (DFFR’d,pred or
DFFR’p,pred) was calculated as DFFRd / (1-wDFFRp) or DFFRp/(1-
kwDFFRd), respectively. Considering DFFRO (DFFR across the
proximal segment to the proximal stenosis), the predicted FFR’d was
[1–DFFRO –DFFR’pred]. For in vivo validation, twenty patients with a
tandem lesion (DS>50% for each stenosis) were evaluated. After
stenting a stenosis with a larger DFFR, post-stenting FFR’d was re-
measured and compared with the calculated FFR’d,pred. The accuracy
was also compared with a previous model that did not consider a side
branch ﬂow.
RESULTS FFR’d,pred using our model (vs. previous model) showed a
closer correlation with the measured FFR’d (R2¼0.88 vs 0.80) and a
greater prediction power in terms of mean absolute error (0.030.02
vs 0.040.03, p¼0.045), (Figure A and B). When FFR gradients across
proximal and distal stenosis were equal (DFFRp¼DFFRd), prioritizing
treatment of distal (vs. proximal) stenosis was more effective to
reduce the residual FFR gradient (Figure C). Especially in tandem
lesions with a big side branch and a large sum of DFFRd and DFFRp,
even with a slightly larger DFFRp (vs. DFFRd), consequent FFR
recovery was less effective compared to distal stenosis treatment
(’disagreement zone’ in Figure D).CONCLUSIONS Our prediction model accurately predicts FFR’d after
treatment of a stenosis and is useful to optimize treatment strategy in
tandem lesion.
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BACKGROUND Fractional Flow Reserve (FFR) has become the stan-
dard method of assessing the physiological severity of intermediate
coronary artery stenosis. It requires maximum hyperemia. Tradi-
tionally Adenosine has been used. Regadenoson, a selective A2A re-
ceptor agonist, is an approved hyperemic agent for pharmacological
stress imaging, its role for measuring FFR is unknown. We therefore
systematically reviewed published literature to compare the efﬁcacy
and safety between those two drugs in measuring FFR.
METHODS We searched PubMed, Cochrane Library & Web of Science
for randomized controlled trials (RCT) comparing the use of Adeno-
sine versus Regadenoson in measuring FFR. The primary endpoint
was the correlation of FFR values using those two drugs. We also
assessed the change in mean blood pressure, heart rate, and devel-
opment of advanced heart block as safety outcomes. Odd ratio and
95% conﬁdence intervals were used to evaluate categorical variables.
Standard difference in the mean and 95% conﬁdence intervals were
used to evaluate continuous variables. All the analysis was done with
the Der Simonian and Laird random effect model. Sensitivity and
cumulative analysis were performed for each outcome.
RESULTS A total of 4 RCT with a total of 202 patients were included.
Each patient underwent FFR measurement using IV Adenosine ﬁrst
then with IV Regadenoson. A strong linear correlation of FFR was
noted in between the two methods. The pooled mean correlation
factor was R 0.981. There was no statistically signiﬁcant difference in
mean FFR values between both groups (Sdm -0.87, CI ¼ [-1.08,-0.09],
P¼ 0.07). The standard mean difference was lower with sensitivity
analysis but remained statistically insigniﬁcant (Sdm -0.008, CI ¼
[-0.21,1.9], P¼0.94). Change in heart rate were less in Adenosine arm
